Anthera Pharmaceuticals Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares, Can Purchase 500K Additional Shares to 3.833M Offered at $7.50/Share
July 14, 2015 at 12:06 PM EDT
Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), today announced that it has completed the previously announced underwritten public ...
